(Caixin-China) Coco Feng - Chinese drugmaker Kanghong has completed the first step of a $47-million deal to exclusively run the China operations of Israeli glaucoma-treatment-developer IOPtima Ltd. East Asians experience the highest rate of blindness in the world from one of the two most common types of glaucoma, and ethnic Chinese and South Asians are at significantly higher risk for angle-closure glaucoma.
2018-04-04 00:00:00Full ArticleBACK Visit the Daily Alert Archive